Business Context and Reporting Period
This Form 8-K Current Report is filed by Akers Biosciences, Inc. (the "Company"), an emerging growth company incorporated in New Jersey. The report date is June 1, 2018, covering events occurring on May 27, 2018, and May 30, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on corporate governance and internal review matters rather than financial performance data.
Material Changes and Events
- Resignation of Director: Raymond F. Akers, Jr. submitted his resignation from the Board of Directors effective immediately on May 27, 2018.
- Disagreement Disclosure: While the initial resignation letter stated no disagreement, Dr. Akers subsequently submitted a "Disagreement Letter" dated May 30, 2018.
- Reason for Departure: The Company attributes the resignation to significant differences between Dr. Akers and other Board members regarding the management of the Company, its accounting and business practices, and its legal counsel.
- Audit Committee Review: The Company's audit committee is reviewing revenue recognition items for the first quarter of 2018 and previous quarters. The Company states that Dr. Akers has not been fully cooperative in this review.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, financial outlook, or standard risk factor disclosures. The primary risk highlighted is the internal governance conflict and the ongoing review of historical revenue recognition practices, which suggests potential accounting contingencies.
Investor Verification Checklist
- Review the attached Resignation Letter (Exhibit 17.1) and Disagreement Letter (Exhibit 17.2) for specific details on the nature of the disagreements.
- Monitor future filings for the outcome of the audit committee's review of Q1 2018 and prior quarter revenue recognition.
- Verify if the lack of cooperation from the departing director impacts the Company's ability to finalize its financial statements or audit.
- Check for any subsequent announcements regarding the appointment of a new director to fill the vacancy.